Skip to content
DraconiticResearch
Search Sources API
201,818 studies31 sourcesUpdated 40 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

931 A TCF7 phosphorylation checkpoint controls B7-H3 CAR-T cell persistence in solid tumors and brain metastases

  • Mien-Chie Hung1
  • Jun Yao2
  • Zhou Jiang3
  • Liuqing Yang4
  • Ziyi Li5
  • Heng-Huan Lee3
  • Chunru Lin6
  • Xi Hu6
  • Ashley V Makela6
  • Yu-yi Chu6
6 affiliations
  1. 1Graduate Institute of Biomedical Sciences, Graduate Institute of Biochemistry and Molecular Biology, Research Center for Cancer Biology and Center for Molecular Medicine, China Medical University, Taichung, Taiwan
  2. 2Center for Reproductive Medicine, Department of Obstetrics, Zhejiang Provincial People’s Hospital, (Affiliated People’s Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, China
  3. 3Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
  4. 4Department of Infectious Diseases, National Clinical Research Center for Infectious Disease, Shenzhen Third People`s Hospital, The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China
  5. 51 Department of Urology, Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China
  6. 6The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Open at sourcePDFDOICite

Related

  1. 971 The impact of liver metastases on immune-related adverse events in stage IV patients treated with immune-checkpoint inhibitors: a real-world, multicenter, retrospective study
    Adil Alaoui, Jessica A Catterson, Michael B Atkins +4
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textOncologyDOAJ
  2. 270 AgenT-797, an allogeneic iNKT cell therapy, enables tumor-cell killing in a human organoid model of immune checkpoint inhibitor–refractory colorectal cancer liver metastases
    Nils-Petter Rudqvist, Bishnu Joshi, Dhan Chand +8
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textOncologyDOAJ
  3. High concordance in molecular profiles between primary tumors and matched lymph node metastases in differentiated thyroid carcinoma: implications for clinical sample selection
    Yijin Pan, Yuqing Sun, Cong Shi +4
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textEndocrinology & metabolismCrossref
  4. Optimized dosing of spatially heterogeneous radiopharmaceutical therapy reprograms poorly immunogenic tumors to enhance response to immune checkpoint blockade
    M. E. Takashima, Z. Danaceau, M. Bio Idrissou +13
    bioRxivPreprintAll rights reservedFull textOncologybioRxivPMC
  5. 456 External validation of the SITC consensus definitions of primary and secondary resistance to immune checkpoint inhibitors in patients with solid tumors
    Ali Awada, Sary Faraj, Ali Tarhini +13
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textOncologyDOAJ

Cite

BibTeXRIS
BibTeX
@article{hung2026tcf7,
  title = {{931 A TCF7 phosphorylation checkpoint controls B7-H3 CAR-T cell persistence in solid tumors and brain metastases}},
  author = {Mien-Chie Hung and Jun Yao and Zhou Jiang and Liuqing Yang and Ziyi Li and Heng-Huan Lee and Chunru Lin and Xi Hu and Ashley V Makela and Yu-yi Chu},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.0931},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.0931},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 931 A TCF7 phosphorylation checkpoint controls B7-H3 CAR-T cell persistence in solid tumors and brain metastases
AU  - Mien-Chie Hung
AU  - Jun Yao
AU  - Zhou Jiang
AU  - Liuqing Yang
AU  - Ziyi Li
AU  - Heng-Huan Lee
AU  - Chunru Lin
AU  - Xi Hu
AU  - Ashley V Makela
AU  - Yu-yi Chu
PY  - 2026
DA  - 2026/11/06
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.0931
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.0931
SN  - 2051-1426
ER  -